$14.46
-1.31-8.31%
Last update: Oct 30, 6:34 PM
Generate Biomedicines Inc (GENB) Stock Price, Quote, News & History
GENBNASDAQ
Generate Biomedicines & Zealand Pharma team up to develop AI-engineered protein therapies for obesity & metabolic diseases.
You can purchase shares of Generate Biomedicines (NASDAQ:GENB) through any online brokerage.
Other companies in Generate Biomedicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Generate Biomedicines has a consensus price target of $26.40.
The stock price for Generate Biomedicines (NASDAQ: GENB) is $14.49 last updated October 30, 2026 at 6:34 PM EDT.
There are no upcoming dividends for Generate Biomedicines.
Generate Biomedicines does not have any upcoming earnings scheduled.
There is no upcoming split for Generate Biomedicines.
Generate Biomedicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using...
